Value-Based Medicine News
Telehealth Has Many Benefits in GI Care, Says Oshi Health's Sam HollidayMay 20th 2023
Telehealth provides more flexibility for patients with gastrointestinal issues to better fit their care into their lives and around symptoms they may be experiencing, said Sam Holliday, co-founder and CEO of Oshi Health.
Dr Stephen Schleicher: We’re at a Turning Point in Oncology CareMarch 2nd 2023
Stephen M. Schleicher, MD, MBA, chief medical officer at Tennessee Oncology, discusses the present state of value-based oncology care and what the future may bring when the Enhancing Oncology Model kicks off on July 1.
Meet Dr Ishani Ganguli, Seema S. Sonnad Emerging Leader in Managed Care Research Award RecipientNovember 10th 2022
Ishani Ganguli, MD, MPH, assistant professor of medicine at Harvard Medical School, physician at Brigham and Women’s Hospital, reacts to receiving the 2022 Seema S. Sonnad Emerging Leader in Managed Care Research Award.
Dr Neil Iyengar Emphasizes Importance of Population Health Lens in Oncology at PCOC 2022November 10th 2022
Population health brings an important lens to both oncology practice and research, said Neil Iyengar, MD, associate attending physician, breast medical service, Memorial Sloan Kettering Cancer Center.
Dr Stephen Schleicher: Culture, People, Analytics Contributed to OCM SuccessOctober 2nd 2022
Co-hosted by Memorial Sloan Kettering Cancer Center, the most recent Institute for Value-Based Medicine® event took place on September 22, with a focus on improving cancer care delivery through innovation.
Gluckman Calls for Better Data, Payer Policies to Drive Value-Based CV CareJuly 30th 2022
Ty J. Gluckman, MD, FACC, FAHA, who is medical director of the Center for Cardiovascular Analytics, Research, and Data Science at Providence St. Joseph Health in Portland, Oregon, addressed the 2022 Congress of the American Society for Preventive Cardiology meeting in Louisville, Kentucky.
Nathan H. Walcker on Expectations for Stakeholders Attending Tampa IVBM MeetingApril 27th 2022
Nathan H. Walcker, MBA, chief executive officer, Florida Cancer Specialists & Research Institute (FCSRI), discusses what guests can expect at the in-person Tampa meeting of The American Journal of Managed Care®'s Institute for Value-Based Medicine® (IVBM), co-hosted by FCSRI.
Dr Michael Diaz Previews In-person Tampa IVBM MeetingApril 26th 2022
Michael Diaz, MD, president and managing physician, Florida Cancer Specialists & Research Institute, previews the Tampa meeting of The American Journal of Managed Care®'s Institute for Value-Based Medicine® (IVBM), cohosted by Florida Cancer Specialists & Research Institute.
What's Next After OCM? Possibly a Gap and Something Mandatory, Experts PredictSeptember 25th 2021
With the Oncology Care Model (OCM) slated to end in 2022, the successor model is still not in place. According to panelists, there is likely going to be a gap after OCM ends and the new model begins, but more importantly, practices should prepare for the new model to be mandatory.
Biden Administration Drug Plan Includes Value-Based Payment Ideas for MedicareSeptember 9th 2021
The administration said it would make the results of its drug price negotiations with manufacturers, as well as its approach to value-based care models, open to a variety of payers.
Whole-Person Health Care: Integrating Mental and Behavioral Health Into Primary CareOctober 16th 2020
Panelists highlight approaches for integrating behavioral and physical health into a whole-patient model and discuss emerging opportunities for the integration of behavioral mental health in value-based care.
Experts Argue COVID-19 Provides Opportunity to Implement Value-Based Care PracticesAugust 13th 2020
In a webinar, experts outlined challenges providers face amid the coronavirus disease 2019 (COVID-19) pandemic and the benefits of increased access to high-value care during the outbreak and beyond.
Supplemental Process Can Aid in Assessing Value of Rare Disease TreatmentsJuly 25th 2020
A study looking at the ways in which different countries handle appraisal and reimbursement processes for rare disease treatments (RDTs) revealed that implementing supplemental processes can aid in patient and physician decision making.